P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine (ACT KNOW)
Artesunate-mefloquine vs Chloroquine in Patients With Acute Uncomplicated P. Knowlesi and P. Vivax Malaria: a Randomized Open Label Trial in Sabah, Malaysia
Sponsor: Menzies School of Health Research
A PHASE3 clinical study on Uncomplicated Plasmodium Knowlesi Malaria, this trial is completed. The trial is conducted by Menzies School of Health Research and has accumulated 5 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Menzies School of Health Research
- Ministry of Health, Malaysia
For direct contact, visit the study record on ClinicalTrials.gov .